This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Feb 9;96(6):295-296.

doi: 10.1212/WNL.0000000000011403.

Author Response: Evaluation of Efficacy and Tolerability of First-Line Therapies in NMOSD

Helene Zephir¹, Julien Poupart¹, Romain Deschamps², Bertrand Audoin³, Jonathan Ciron⁴, Elisabeth Maillart², Caroline Papeix², Nicolas Collongues⁵, Bertrand Bourre⁶, Mickaël Cohen⁷, Sandrine Wiertlewski⁸, Olivier Outteryck¹, David Laplaud⁸, Sandra Vukusic⁹, Romain Marignier⁹, Jonathan Giovannelli¹

Affiliations

Affiliations

¹ (Lille, France).
² (Paris).
³ (Marseille, France).
⁴ (Toulouse, France).
⁵ (Strasbourg, France).
⁶ (Rouen, France).
⁷ (Nice, France).
⁸ (Nantes, France).
⁹ (Lyon, France).

PMID: 33558403
DOI: 10.1212/WNL.0000000000011403

Comment

Author Response: Evaluation of Efficacy and Tolerability of First-Line Therapies in NMOSD

Helene Zephir et al. Neurology. 2021.

. 2021 Feb 9;96(6):295-296.

doi: 10.1212/WNL.0000000000011403.

Authors

Helene Zephir¹, Julien Poupart¹, Romain Deschamps², Bertrand Audoin³, Jonathan Ciron⁴, Elisabeth Maillart², Caroline Papeix², Nicolas Collongues⁵, Bertrand Bourre⁶, Mickaël Cohen⁷, Sandrine Wiertlewski⁸, Olivier Outteryck¹, David Laplaud⁸, Sandra Vukusic⁹, Romain Marignier⁹, Jonathan Giovannelli¹

Affiliations

¹ (Lille, France).
² (Paris).
³ (Marseille, France).
⁴ (Toulouse, France).
⁵ (Strasbourg, France).
⁶ (Rouen, France).
⁷ (Nice, France).
⁸ (Nantes, France).
⁹ (Lyon, France).

PMID: 33558403
DOI: 10.1212/WNL.0000000000011403

No abstract available

PubMed Disclaimer

Comment on

Evaluation of efficacy and tolerability of first-line therapies in NMOSD.
Poupart J, Giovannelli J, Deschamps R, Audoin B, Ciron J, Maillart E, Papeix C, Collongues N, Bourre B, Cohen M, Wiertlewski S, Outteryck O, Laplaud D, Vukusic S, Marignier R, Zephir H; NOMADMUS study group. Poupart J, et al. Neurology. 2020 Apr 14;94(15):e1645-e1656. doi: 10.1212/WNL.0000000000009245. Epub 2020 Mar 13. Neurology. 2020. PMID: 32170036
Reader Response: Evaluation of Efficacy and Tolerability of First-Line Therapies in NMOSD.
Leite MI. Leite MI. Neurology. 2021 Feb 9;96(6):294-295. doi: 10.1212/WNL.0000000000011401. Neurology. 2021. PMID: 33558402 No abstract available.

Publication types

Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon